financetom
Business
financetom
/
Business
/
BCP Investment Corp Q3 net investment income jumps, helped by Logan Ridge acquisition
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BCP Investment Corp Q3 net investment income jumps, helped by Logan Ridge acquisition
Nov 6, 2025 2:47 PM

Overview

* BCP Q3 total investment income rises 50% to $18.9 mln

* Net investment income for Q3 increases 94.2% to $8.8 mln

* Company launches $9 mln modified Dutch auction tender offer

Outlook

* BCP Investment Corp ( BCIC ) expects to repurchase up to 10% of its common stock by year-end

* Company plans a $9.0 mln Dutch auction tender offer starting November 10, 2025

Result Drivers

* MERGER IMPACT - Merger with Logan Ridge Finance Corp increased scale and portfolio diversification, enhancing operating efficiencies

* INCOME GROWTH - Total investment income rose 50% to $18.9 mln, driven by increased interest income from Debt Securities Portfolio

* SHARE REPURCHASE - Co launches $9 mln modified Dutch auction tender offer to repurchase shares and enhance shareholder value

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Net $231.30

Asset mln

Value

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the closed end funds peer group is "buy"

* Wall Street's median 12-month price target for BCP Investment Corp ( BCIC ) is $15.00, about 19.5% above its November 5 closing price of $12.08

* The stock recently traded at 6 times the next 12-month earnings vs. a P/E of 6 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Sportradar Group Q2 Earnings, Revenue Rise; Raises 2025 Revenue Guidance
Sportradar Group Q2 Earnings, Revenue Rise; Raises 2025 Revenue Guidance
Aug 5, 2025
07:46 AM EDT, 08/05/2025 (MT Newswires) -- Sportradar Group ( SRAD ) reported Q2 earnings Tuesday of 0.15 euros ($0.17) per diluted class A share, up from breakeven a year earlier. Analysts polled by FactSet expected 0.04 euros. Revenue for the quarter ended June 30 was 317.8 million euros, compared with 278.4 million euros a year earlier. Analysts surveyed by...
Organon beats Q2 revenue expectations, raises FY guidance
Organon beats Q2 revenue expectations, raises FY guidance
Aug 5, 2025
Overview * Organon Q2 revenue of $1.594 bln beats analyst expectations; raises full-year guidance * Adjusted EPS of $1.00 exceeds estimates, indicating strong performance * Company repaid $345 mln of long-term debt Outlook * Organon raises 2025 revenue guidance to $6.275 bln-$6.375 bln * Company affirms 2025 adjusted EBITDA margin guidance at 31%-32% * Organon targets net leverage below 4.0x...
Harmony Biosciences Q2 revenue misses estimates
Harmony Biosciences Q2 revenue misses estimates
Aug 5, 2025
Overview * Harmony Biosciences Q2 2025 revenue grows 16% YoY but misses analyst expectations * Company reaffirms 2025 revenue guidance, maintaining $820-$860 mln target * Harmony on track for Phase 3 ZYN002 trial results in Fragile X syndrome, Q3 2025 Outlook * Harmony reaffirms 2025 revenue guidance of $820 mln to $860 mln * Company on track for Phase 3...
Copyright 2023-2026 - www.financetom.com All Rights Reserved